PHAXIAM Therapeutics S.A. (PHXM) — Cash Flow Quality Index

Latest as of December 2022: -1.87x

PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Quality Index of -1.87x as of December 2022. Operating cash flow of €-11.10 Million is below net income of €5.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PHAXIAM Therapeutics S.A. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.87x

Operating CF / Net Income

Operating Cash Flow

€-11.10 Million

EUR

Net Income

€5.93 Million

EUR

Data as of

Dec 2022

Most recent filing

Annual Cash Flow Quality Index for PHAXIAM Therapeutics S.A. (None–None)

Year-by-year earnings quality comparison for PHAXIAM Therapeutics S.A..

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.